中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2015年
10期
1539-1543
,共5页
尹飚%杨逸禧%杨波%王簕%黎双庆%杨富国
尹飚%楊逸禧%楊波%王簕%黎雙慶%楊富國
윤표%양일희%양파%왕륵%려쌍경%양부국
干细胞%骨髓干细胞%慢病毒%增强型红色荧光基因%人骨髓间充质干细胞%转染%国家自然科学基金
榦細胞%骨髓榦細胞%慢病毒%增彊型紅色熒光基因%人骨髓間充質榦細胞%轉染%國傢自然科學基金
간세포%골수간세포%만병독%증강형홍색형광기인%인골수간충질간세포%전염%국가자연과학기금
Bone Marrow%Mesenchymal Stem Cels%Lentivirus Infections
背景:掌握转染的最佳感染复数和产生较强荧光强度的时间,可为后期观察人骨髓间充质干细胞在动物模型体内的示踪奠定基础。目的:探讨HIV-1来源的慢病毒携带增强型红色荧光蛋白转染人骨髓间充质干细胞的可行性。方法:将第4代人骨髓间充质干细胞分成空白组和感染复数为2,3,4组,以细胞数5.0×105个接种于12孔培养皿,添加含有体积分数为1%胎牛血清的成人骨髓间质干细胞完全培养基1 mL。调整慢病毒携带增强型红色荧光蛋白感染滴度为1.0×1011 TU/L,加入各组培养皿中病毒液体积分别为10,15,20μL,感染复数分别为2,3,4,空白组加入10μL PBS。转染后24,72 h荧光倒置显微镜观察细胞红色荧光表达情况并计算出转染率。结果与结论:增强型红色荧光蛋白在骨髓间充质干细胞中稳定表达,转染后24 h倒置荧光显微镜下可见红色荧光,72 h荧光达到最强,细胞转染率与感染复数值呈线性增长关系。转染后21 d内,各转染实验组的人骨髓间充质干细胞数量与空白组比较差异无显著性意义(P >0.05),以上结果提示采用 HIV-1来源的慢病毒载体介导增强型红色荧光蛋白转染标记人骨髓间充质干细胞是可行的,当感染复数为4时转染效率高并可持续表达至少21 d,且标记后对其增殖活性无影响。
揹景:掌握轉染的最佳感染複數和產生較彊熒光彊度的時間,可為後期觀察人骨髓間充質榦細胞在動物模型體內的示蹤奠定基礎。目的:探討HIV-1來源的慢病毒攜帶增彊型紅色熒光蛋白轉染人骨髓間充質榦細胞的可行性。方法:將第4代人骨髓間充質榦細胞分成空白組和感染複數為2,3,4組,以細胞數5.0×105箇接種于12孔培養皿,添加含有體積分數為1%胎牛血清的成人骨髓間質榦細胞完全培養基1 mL。調整慢病毒攜帶增彊型紅色熒光蛋白感染滴度為1.0×1011 TU/L,加入各組培養皿中病毒液體積分彆為10,15,20μL,感染複數分彆為2,3,4,空白組加入10μL PBS。轉染後24,72 h熒光倒置顯微鏡觀察細胞紅色熒光錶達情況併計算齣轉染率。結果與結論:增彊型紅色熒光蛋白在骨髓間充質榦細胞中穩定錶達,轉染後24 h倒置熒光顯微鏡下可見紅色熒光,72 h熒光達到最彊,細胞轉染率與感染複數值呈線性增長關繫。轉染後21 d內,各轉染實驗組的人骨髓間充質榦細胞數量與空白組比較差異無顯著性意義(P >0.05),以上結果提示採用 HIV-1來源的慢病毒載體介導增彊型紅色熒光蛋白轉染標記人骨髓間充質榦細胞是可行的,噹感染複數為4時轉染效率高併可持續錶達至少21 d,且標記後對其增殖活性無影響。
배경:장악전염적최가감염복수화산생교강형광강도적시간,가위후기관찰인골수간충질간세포재동물모형체내적시종전정기출。목적:탐토HIV-1래원적만병독휴대증강형홍색형광단백전염인골수간충질간세포적가행성。방법:장제4대인골수간충질간세포분성공백조화감염복수위2,3,4조,이세포수5.0×105개접충우12공배양명,첨가함유체적분수위1%태우혈청적성인골수간질간세포완전배양기1 mL。조정만병독휴대증강형홍색형광단백감염적도위1.0×1011 TU/L,가입각조배양명중병독액체적분별위10,15,20μL,감염복수분별위2,3,4,공백조가입10μL PBS。전염후24,72 h형광도치현미경관찰세포홍색형광표체정황병계산출전염솔。결과여결론:증강형홍색형광단백재골수간충질간세포중은정표체,전염후24 h도치형광현미경하가견홍색형광,72 h형광체도최강,세포전염솔여감염복수치정선성증장관계。전염후21 d내,각전염실험조적인골수간충질간세포수량여공백조비교차이무현저성의의(P >0.05),이상결과제시채용 HIV-1래원적만병독재체개도증강형홍색형광단백전염표기인골수간충질간세포시가행적,당감염복수위4시전염효솔고병가지속표체지소21 d,차표기후대기증식활성무영향。
BACKGROUND:To grasp the optimal multiplicity of infection (MOI) and the time when stronger fluorescence intensities produce can lay the foundation for tracing observation of human bone marrow mesenchymal stem celsin vivo in animal models. OBJECTIVE:To investigate the feasibility of HIV-1 lentivirus carrying enhanced red fluorescent protein to transfect human bone marrow mesenchymal stem cels. METHODS:Human bone marrow mesenchymal stem cels at passage 4 were divided into blank group and MOI 2, 3, 4 groups. After that, the cels were seeded into 12-wel plates at a density of 5.0×105 , and cultured in 1 mL complete medium for adult bone marrow mesenchymal stem cels containing 1% fetal bovine serum. The infectious titer of lentivirus-carried enhanced red fluorescent protein was adjusted to 1.0×10 11 TU/L. Lentivirus solution 10, 15, 20 μL at MOI=2, 3, 4 were respectively added into the MOI 2, 3, 4 groups, and 10μL PBS was added into the blank group. At 24 and 72 hours after transfection, the expression of red fluorescence was observed under an inverted fluorescence microscope and the transfection efficiency was calculated. RESULTS AND CONCLUSION:Enhanced red fluorescent protein expressed stably in bone marrow mesenchymal stem cels. At 24 hours after transfection, red fluorescence could be seen under the inverted fluorescence microscope and achieved the peak at 72 hours after transfection. Within 21 days after transfection, there were no differences in the number of human bone marrow mesenchymal stem cels between the MOI 2, 3, 4 groups and blank group (P > 0.05). These results show that the HIV-1 lentivirus carrying enhanced red fluorescent protein is feasible to transfect human bone marrow mesenchymal stem cels, with the highest transfection efficiency when the MOI=4, which can express at least for 21 days and have no effects on the proliferative activity of labeled cels.